{"basic_info": {"ticker": "6185", "exchange": "XHKG", "bloomberg_ticker": "6185 HK Equity", "name": "CANSINO BIOLOGICS INC-H", "industry": "Pharmaceuticals", "name_chinese_simplified": "康希诺生物股份公司", "period": "2020", "market_value": 75685134336, "total_income": 18544000, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 18544000, "business_income_over_total_income": 1.0}, {"shariah_compliance": "unknown", "income": 0, "business_income_over_total_income": 0.0}], "details": [{"business_activity_cn": "销售疫苗产品", "business_activity_en": "Sales vaccine products", "income": 18544000, "business_income_over_total_income": 1.0, "shariah_compliance": "compliant"}, {"business_activity_cn": "未分配", "business_activity_en": "Unassigned", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.0013123537212967583, "shariah_compliance": "compliant", "amount_over_market_value": 0.0013123537212967583}]}